Centogene Cash Flow from Investing Activities 2019-2023 | CNTG
Centogene cash flow from investing activities from 2019 to 2023. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| Centogene Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2023 | $2 |
| 2022 | $-1 |
| 2021 | $-6 |
| 2020 | $-18 |
| 2019 | $16 |
| 2018 | $-10 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.053B |
| Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company?s goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using their knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.947B | 19.74 |
| Inspire Medical Systems (INSP) | United States | $4.693B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.102B | 0.00 |
| Axonics (AXNX) | United States | $3.425B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.987B | 0.00 |
| Azenta (AZTA) | United States | $2.753B | 154.79 |
| IRhythm Technologies (IRTC) | United States | $2.730B | 0.00 |
| Enovis (ENOV) | United States | $2.727B | 20.21 |
| 10x Genomics (TXG) | United States | $2.705B | 0.00 |
| Privia Health (PRVA) | United States | $2.062B | 115.20 |
| Schrodinger (SDGR) | United States | $1.607B | 0.00 |
| Omnicell (OMCL) | United States | $1.488B | 51.43 |
| Phreesia (PHR) | United States | $1.296B | 0.00 |
| Standard BioTools (LAB) | United States | $0.936B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.647B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.645B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.501B | 0.00 |
| Talkspace (TALK) | United States | $0.480B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.403B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| Pulmonx (LUNG) | United States | $0.311B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.217B | 0.00 |
| Outset Medical (OM) | United States | $0.206B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.171B | 0.00 |
| TruBridge (TBRG) | United States | $0.146B | 7.87 |
| American Well (AMWL) | United States | $0.128B | 0.00 |
| 111 (YI) | China | $0.109B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.102B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.080B | 0.00 |
| HeartBeam (BEAT) | United States | $0.077B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.068B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.046B | 0.00 |
| CareCloud (CCLD) | United States | $0.044B | 0.00 |
| Movano (MOVE) | United States | $0.040B | 0.00 |
| Akili (AKLI) | United States | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Cue Health (HLTH) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |